Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Joyce Lee

Concepts (316)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Diseases, Interstitial
59
2025
611
12.460
 Why?
Idiopathic Pulmonary Fibrosis
61
2025
634
12.040
 Why?
Arthritis, Rheumatoid
22
2025
1098
4.360
 Why?
Scleroderma, Systemic
9
2024
114
2.380
 Why?
Immunosuppressive Agents
7
2024
858
1.940
 Why?
Connective Tissue Diseases
9
2021
82
1.810
 Why?
Mucin-5B
5
2025
215
1.670
 Why?
Lung
24
2025
3940
1.550
 Why?
Autoimmune Diseases
10
2024
428
1.450
 Why?
Vital Capacity
14
2024
290
1.340
 Why?
Rheumatic Diseases
5
2024
69
1.320
 Why?
Gastroesophageal Reflux
5
2020
232
1.320
 Why?
Disease Progression
12
2024
2628
1.310
 Why?
Tomography, X-Ray Computed
21
2025
2511
1.260
 Why?
Pulmonary Fibrosis
10
2025
385
1.240
 Why?
Prognosis
22
2024
3773
1.090
 Why?
Alveolitis, Extrinsic Allergic
6
2022
97
1.030
 Why?
Humans
119
2025
129847
1.000
 Why?
Respiratory Aspiration
4
2020
31
0.980
 Why?
Quality of Life
4
2024
2695
0.920
 Why?
Idiopathic Interstitial Pneumonias
4
2019
49
0.890
 Why?
Middle Aged
49
2025
31177
0.860
 Why?
Aged
46
2025
22107
0.860
 Why?
Biomarkers
11
2025
3971
0.850
 Why?
Telomerase
2
2023
231
0.810
 Why?
Pulmonary Surfactants
1
2023
106
0.790
 Why?
Telomere
2
2024
232
0.780
 Why?
Cryptogenic Organizing Pneumonia
1
2022
19
0.770
 Why?
Histamine H2 Antagonists
2
2013
29
0.770
 Why?
Glucocorticoids
3
2024
582
0.760
 Why?
Matrix Metalloproteinase 7
1
2021
26
0.750
 Why?
Proton Pump Inhibitors
2
2013
100
0.730
 Why?
Proteomics
3
2025
1058
0.720
 Why?
Rheumatology
5
2024
107
0.690
 Why?
Male
62
2025
63759
0.690
 Why?
Adrenal Cortex Hormones
3
2021
532
0.680
 Why?
Respiratory Function Tests
10
2025
581
0.680
 Why?
Lung Transplantation
9
2025
290
0.650
 Why?
Cellular Senescence
1
2021
173
0.640
 Why?
Female
61
2025
68829
0.620
 Why?
Diagnosis, Differential
8
2022
1434
0.610
 Why?
Myositis
3
2024
51
0.590
 Why?
Prospective Studies
11
2025
7158
0.520
 Why?
Dyspnea
5
2023
239
0.520
 Why?
Patient Satisfaction
2
2021
639
0.510
 Why?
Risk Assessment
10
2021
3269
0.500
 Why?
Forecasting
1
2017
361
0.500
 Why?
Severity of Illness Index
8
2018
2739
0.480
 Why?
Survival Rate
10
2020
1872
0.460
 Why?
Longitudinal Studies
8
2017
2724
0.450
 Why?
Cohort Studies
13
2025
5444
0.450
 Why?
Genetic Predisposition to Disease
2
2022
2271
0.440
 Why?
Patient Education as Topic
2
2016
743
0.430
 Why?
Azathioprine
2
2024
50
0.420
 Why?
Precision Medicine
1
2017
385
0.420
 Why?
Pulmonary Diffusing Capacity
5
2020
74
0.410
 Why?
Rituximab
2
2024
164
0.390
 Why?
Hypertension, Pulmonary
3
2022
1897
0.390
 Why?
Pepsin A
1
2011
19
0.380
 Why?
Antirheumatic Agents
4
2024
280
0.380
 Why?
Comprehensive Health Care
1
2011
21
0.370
 Why?
Veterans
4
2023
1383
0.360
 Why?
Sleep Apnea, Obstructive
1
2015
279
0.360
 Why?
Fundoplication
1
2011
54
0.360
 Why?
Carbon Monoxide
4
2019
68
0.340
 Why?
Telomere Shortening
2
2024
20
0.330
 Why?
Proportional Hazards Models
7
2024
1199
0.330
 Why?
Bronchoalveolar Lavage Fluid
2
2011
646
0.330
 Why?
Endotoxins
1
2010
220
0.320
 Why?
Sirolimus
1
2011
270
0.320
 Why?
Anti-Bacterial Agents
1
2019
1708
0.320
 Why?
Phenotype
6
2025
3062
0.310
 Why?
Retrospective Studies
16
2024
14553
0.310
 Why?
Emphysema
2
2022
109
0.280
 Why?
Acute Lung Injury
1
2010
280
0.280
 Why?
Mycophenolic Acid
3
2024
110
0.280
 Why?
Lung Diseases
3
2020
743
0.270
 Why?
United States
15
2025
13913
0.270
 Why?
Comorbidity
5
2015
1551
0.270
 Why?
Forced Expiratory Volume
3
2019
508
0.260
 Why?
Depression
1
2015
1323
0.260
 Why?
Prevalence
5
2022
2564
0.260
 Why?
Autoantibodies
2
2015
1468
0.250
 Why?
Predictive Value of Tests
4
2017
1951
0.250
 Why?
Pyridones
2
2024
158
0.240
 Why?
Mutation
3
2023
3706
0.240
 Why?
Aged, 80 and over
10
2024
7066
0.240
 Why?
Pulmonologists
1
2025
15
0.240
 Why?
Sex Factors
4
2020
1973
0.230
 Why?
Endothelium, Vascular
1
2010
902
0.220
 Why?
Case-Control Studies
6
2021
3384
0.220
 Why?
Abatacept
1
2024
46
0.220
 Why?
Chronic Disease
6
2020
1724
0.210
 Why?
Biopsy, Needle
3
2019
187
0.210
 Why?
Indoles
2
2024
387
0.210
 Why?
Blood Proteins
1
2025
245
0.210
 Why?
Sputum
1
2025
302
0.210
 Why?
Polychlorinated Dibenzodioxins
1
2022
6
0.200
 Why?
Transforming Growth Factor beta
1
2025
462
0.200
 Why?
Fibrosis
3
2022
526
0.200
 Why?
Genotype
2
2025
1829
0.190
 Why?
Genetic Testing
1
2025
422
0.190
 Why?
Self Care
2
2017
368
0.190
 Why?
Incidence
5
2023
2646
0.180
 Why?
Monocytes
2
2021
554
0.180
 Why?
Organizational Objectives
1
2021
73
0.180
 Why?
Adult
17
2025
35634
0.180
 Why?
Nursing Research
1
2021
47
0.180
 Why?
Genetic Markers
1
2022
334
0.180
 Why?
Early Diagnosis
1
2022
233
0.170
 Why?
Kaplan-Meier Estimate
5
2017
851
0.170
 Why?
Disease Models, Animal
1
2010
4077
0.170
 Why?
Patient Outcome Assessment
1
2021
127
0.170
 Why?
Smoking
3
2024
1502
0.170
 Why?
Chemokine CX3CL1
1
2020
23
0.170
 Why?
Survival Analysis
3
2012
1271
0.170
 Why?
Disease Management
4
2018
592
0.160
 Why?
Immunohistochemistry
3
2019
1690
0.160
 Why?
Models, Organizational
1
2020
145
0.160
 Why?
Myositis, Inclusion Body
1
2019
8
0.160
 Why?
Pulmonary Emphysema
1
2022
275
0.160
 Why?
Spirometry
2
2017
257
0.160
 Why?
Radiography
2
2011
800
0.150
 Why?
Graft Rejection
2
2020
598
0.150
 Why?
Wnt-5a Protein
1
2018
21
0.150
 Why?
Gain of Function Mutation
1
2018
34
0.150
 Why?
Treatment Outcome
5
2022
10241
0.150
 Why?
Ambulatory Care Facilities
1
2020
228
0.150
 Why?
Body Weight
1
2022
947
0.150
 Why?
Immunity, Innate
1
2024
804
0.150
 Why?
Randomized Controlled Trials as Topic
1
2024
1368
0.150
 Why?
Focus Groups
2
2020
450
0.140
 Why?
Signal Transduction
2
2023
4935
0.140
 Why?
Weight Loss
1
2022
740
0.140
 Why?
Risk Factors
8
2022
9801
0.140
 Why?
Societies, Medical
4
2024
759
0.140
 Why?
International Cooperation
1
2017
177
0.130
 Why?
Myofibroblasts
1
2018
121
0.130
 Why?
Extracellular Vesicles
1
2018
129
0.130
 Why?
Amino Acyl-tRNA Synthetases
1
2016
30
0.130
 Why?
Health Status Indicators
1
2017
166
0.130
 Why?
Practice Patterns, Physicians'
1
2025
1274
0.130
 Why?
Patient-Centered Care
1
2021
508
0.130
 Why?
Tomography Scanners, X-Ray Computed
1
2015
18
0.120
 Why?
Women's Health
1
2018
364
0.120
 Why?
Follow-Up Studies
4
2019
4896
0.120
 Why?
Acute Disease
3
2016
980
0.120
 Why?
Hospitalization
1
2025
2079
0.120
 Why?
Sleep Wake Disorders
1
2018
255
0.120
 Why?
Cause of Death
1
2017
395
0.120
 Why?
Antibiotic Prophylaxis
1
2016
102
0.120
 Why?
Sarcoidosis
1
2017
157
0.120
 Why?
Pulmonary Medicine
1
2015
80
0.110
 Why?
Nails
1
2014
12
0.110
 Why?
Oxygen Inhalation Therapy
1
2016
145
0.110
 Why?
Hyperpigmentation
1
2014
25
0.110
 Why?
Body Mass Index
1
2022
2274
0.110
 Why?
Laparoscopy
1
2018
447
0.110
 Why?
Gene Expression Profiling
1
2020
1686
0.110
 Why?
Bronchodilator Agents
1
2015
245
0.110
 Why?
Arsenic
1
2014
63
0.110
 Why?
Age Factors
3
2019
3161
0.100
 Why?
Diagnostic Imaging
1
2016
326
0.100
 Why?
Interviews as Topic
1
2016
709
0.100
 Why?
Interleukin-13
1
2014
147
0.100
 Why?
Cystic Fibrosis
1
2023
1067
0.100
 Why?
Keratin-18
1
2012
10
0.100
 Why?
Counseling
1
2016
386
0.100
 Why?
Autoimmunity
2
2015
863
0.100
 Why?
Biopsy
4
2018
1089
0.100
 Why?
Maternal Exposure
1
2014
177
0.100
 Why?
Fatigue
1
2014
319
0.100
 Why?
Age Distribution
3
2019
372
0.090
 Why?
Sjogren's Syndrome
2
2024
49
0.090
 Why?
Time Factors
2
2024
6550
0.090
 Why?
Algorithms
2
2016
1617
0.090
 Why?
Everolimus
1
2011
88
0.090
 Why?
Dermatitis, Atopic
1
2014
319
0.090
 Why?
Epithelial Cells
2
2014
1063
0.090
 Why?
Goals
1
2011
163
0.080
 Why?
Sodium-Potassium-Exchanging ATPase
1
2010
51
0.080
 Why?
Delphi Technique
2
2022
227
0.080
 Why?
Fetus
1
2014
782
0.080
 Why?
Qualitative Research
1
2016
1235
0.080
 Why?
Alveolar Epithelial Cells
1
2010
107
0.080
 Why?
Health Status
1
2014
758
0.080
 Why?
Sensitivity and Specificity
1
2013
1847
0.080
 Why?
Virus Diseases
1
2011
210
0.070
 Why?
Syndrome
2
2022
338
0.070
 Why?
Models, Statistical
1
2012
624
0.070
 Why?
Animals
6
2025
35409
0.070
 Why?
Proto-Oncogene Proteins c-akt
1
2010
434
0.070
 Why?
DNA
1
2014
1406
0.070
 Why?
Antibodies, Monoclonal
1
2014
1368
0.070
 Why?
Pulmonary Alveoli
2
2025
403
0.070
 Why?
Mass Screening
2
2024
1192
0.060
 Why?
Cell Membrane
1
2010
734
0.060
 Why?
Internationality
2
2017
150
0.060
 Why?
Promoter Regions, Genetic
2
2021
1213
0.060
 Why?
Pulmonary Surfactant-Associated Protein D
1
2025
35
0.060
 Why?
Methotrexate
2
2021
249
0.060
 Why?
Palliative Care
1
2011
706
0.060
 Why?
Pandemics
2
2024
1500
0.060
 Why?
Mixed Connective Tissue Disease
1
2024
10
0.060
 Why?
Prednisone
2
2019
234
0.060
 Why?
Sex Distribution
2
2015
359
0.050
 Why?
Walk Test
1
2024
70
0.050
 Why?
Professional Practice Gaps
1
2023
15
0.050
 Why?
Adaptive Immunity
1
2024
161
0.050
 Why?
Demography
1
2024
279
0.050
 Why?
Agent Orange
1
2022
1
0.050
 Why?
2,4,5-Trichlorophenoxyacetic Acid
1
2022
1
0.050
 Why?
2,4-Dichlorophenoxyacetic Acid
1
2022
10
0.050
 Why?
Antibody Formation
1
2024
291
0.050
 Why?
Whole Genome Sequencing
1
2023
128
0.050
 Why?
Respiratory Mucosa
1
2025
310
0.050
 Why?
Exome
1
2023
216
0.050
 Why?
Probability
1
2022
304
0.050
 Why?
Family
1
2025
646
0.040
 Why?
Bayes Theorem
1
2022
374
0.040
 Why?
CX3C Chemokine Receptor 1
1
2020
20
0.040
 Why?
Mice, Inbred C57BL
1
2010
5468
0.040
 Why?
Evidence-Based Medicine
1
2024
716
0.040
 Why?
Allografts
1
2020
137
0.040
 Why?
Total Lung Capacity
1
2019
33
0.040
 Why?
Immunotherapy
1
2024
596
0.040
 Why?
Antibodies, Viral
1
2024
602
0.040
 Why?
Drug Discovery
1
2020
131
0.040
 Why?
Fibroblasts
1
2025
954
0.040
 Why?
Insulin
1
2010
2330
0.040
 Why?
Ireland
1
2019
27
0.040
 Why?
Dermatomyositis
1
2019
26
0.040
 Why?
Echocardiography
1
2022
636
0.040
 Why?
Rare Diseases
1
2019
96
0.040
 Why?
Intention to Treat Analysis
1
2018
68
0.040
 Why?
Hydrogen-Ion Concentration
1
2020
541
0.040
 Why?
National Heart, Lung, and Blood Institute (U.S.)
1
2018
103
0.040
 Why?
United Kingdom
1
2019
258
0.040
 Why?
Behavior
1
2018
92
0.040
 Why?
Education
1
2018
104
0.040
 Why?
Morbidity
1
2018
302
0.040
 Why?
Sleep Apnea Syndromes
1
2018
82
0.040
 Why?
Mice
2
2014
16983
0.030
 Why?
Medicare
1
2023
719
0.030
 Why?
Comprehension
1
2018
165
0.030
 Why?
Linear Models
1
2019
822
0.030
 Why?
Antibodies, Antinuclear
1
2016
66
0.030
 Why?
Muscle Strength
1
2019
304
0.030
 Why?
Global Health
1
2018
329
0.030
 Why?
Flow Cytometry
1
2020
1160
0.030
 Why?
California
1
2017
400
0.030
 Why?
Odds Ratio
1
2018
1022
0.030
 Why?
Gene Expression
1
2020
1465
0.030
 Why?
Evaluation Studies as Topic
1
2015
176
0.030
 Why?
Vaccination
1
2024
1348
0.030
 Why?
Monitoring, Physiologic
1
2017
266
0.030
 Why?
Pneumonia, Aspiration
1
2015
18
0.030
 Why?
Recovery of Function
1
2019
645
0.030
 Why?
Singapore
1
2014
20
0.030
 Why?
Regression Analysis
1
2017
998
0.030
 Why?
Bronchiolitis Obliterans
1
2015
68
0.030
 Why?
Sampling Studies
1
2014
96
0.030
 Why?
San Francisco
1
2014
51
0.030
 Why?
Europe
1
2015
363
0.030
 Why?
Endothelial Cells
1
2020
749
0.030
 Why?
Chicago
1
2014
57
0.030
 Why?
Neck
1
2014
95
0.030
 Why?
Patient Acuity
1
2013
45
0.030
 Why?
Texas
1
2014
237
0.030
 Why?
Mice, SCID
1
2014
350
0.030
 Why?
Observational Studies as Topic
1
2013
110
0.030
 Why?
Enzyme Inhibitors
1
2016
827
0.030
 Why?
Protein Kinase Inhibitors
1
2019
886
0.030
 Why?
Leukocytes
1
2014
306
0.020
 Why?
Young Adult
2
2022
12467
0.020
 Why?
Developing Countries
1
2014
284
0.020
 Why?
Surveys and Questionnaires
1
2025
5437
0.020
 Why?
Endoplasmic Reticulum Stress
1
2012
101
0.020
 Why?
Academic Medical Centers
1
2014
483
0.020
 Why?
Torque teno virus
1
2011
1
0.020
 Why?
DNA Virus Infections
1
2011
3
0.020
 Why?
Molecular Targeted Therapy
1
2014
391
0.020
 Why?
Cells, Cultured
1
2018
4102
0.020
 Why?
Up-Regulation
1
2014
836
0.020
 Why?
Microarray Analysis
1
2011
113
0.020
 Why?
Mass Spectrometry
1
2014
717
0.020
 Why?
Multivariate Analysis
1
2014
1501
0.020
 Why?
Pulmonary Disease, Chronic Obstructive
1
2018
1000
0.020
 Why?
Colorado
1
2020
4410
0.020
 Why?
Models, Theoretical
1
2014
549
0.020
 Why?
Subcellular Fractions
1
2010
80
0.020
 Why?
Body Fluids
1
2010
63
0.020
 Why?
GTPase-Activating Proteins
1
2010
81
0.020
 Why?
Adolescent
2
2022
20451
0.020
 Why?
Practice Guidelines as Topic
1
2017
1514
0.020
 Why?
Inflammation
1
2020
2748
0.020
 Why?
Reproducibility of Results
1
2017
3089
0.020
 Why?
rab GTP-Binding Proteins
1
2010
72
0.020
 Why?
Models, Biological
1
2016
1724
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2011
756
0.020
 Why?
Telemedicine
1
2017
792
0.020
 Why?
Protein Transport
1
2010
429
0.020
 Why?
Polymerase Chain Reaction
1
2011
1033
0.020
 Why?
Sequence Analysis, DNA
1
2011
778
0.020
 Why?
Phosphatidylinositol 3-Kinases
1
2010
362
0.020
 Why?
Cattle
1
2010
978
0.020
 Why?
Logistic Models
1
2012
1989
0.020
 Why?
Respiratory Tract Infections
1
2011
376
0.020
 Why?
Asthma
1
2018
2225
0.010
 Why?
Rats, Sprague-Dawley
1
2010
2403
0.010
 Why?
Apoptosis
1
2012
2489
0.010
 Why?
Cross-Sectional Studies
1
2014
5085
0.010
 Why?
Pregnancy
1
2014
6423
0.010
 Why?
Rats
1
2010
5487
0.010
 Why?
Infant
1
2014
9018
0.010
 Why?
Child
1
2014
20962
0.010
 Why?
Lee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (316) concept(s)
_
Co-Authors Expand Description
See all (31) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)